Published in Stud Health Technol Inform on January 01, 2011
Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2007) 6.34
The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. J Am Coll Cardiol (2013) 4.81
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2013) 3.50
Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. J Am Coll Cardiol (2012) 2.28
[Takotsubo cardiomyopathy: a consensus document]. G Ital Cardiol (Rome) (2008) 2.26
Long-term outcome and risk stratification in dilated cardiolaminopathies. J Am Coll Cardiol (2008) 1.97
Anemia of chronic disease and defective erythropoietin production in patients with celiac disease. Haematologica (2008) 1.72
Cardiovascular manifestations in men and women carrying a FBN1 mutation. Eur Heart J (2010) 1.68
A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur Heart J (2011) 1.67
Clinical and molecular study of 320 children with Marfan syndrome and related type I fibrillinopathies in a series of 1009 probands with pathogenic FBN1 mutations. Pediatrics (2009) 1.67
Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2010) 1.58
Kaposi's sarcoma in transplant and HIV-infected patients: an epidemiologic study in Italy and France. Transplantation (2005) 1.52
Autosomal recessive atrial dilated cardiomyopathy with standstill evolution associated with mutation of Natriuretic Peptide Precursor A. Circ Cardiovasc Genet (2012) 1.49
Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer (2007) 1.40
Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy. Eur Heart J (2009) 1.35
Temporal data mining for the quality assessment of hemodialysis services. Artif Intell Med (2005) 1.27
Mitochondrial DNA variant discovery and evaluation in human Cardiomyopathies through next-generation sequencing. PLoS One (2010) 1.25
Mechanisms of disease: apoptosis in heart failure--seeing hope in death. Nat Clin Pract Cardiovasc Med (2006) 1.24
Noncompaction of the left ventricle: primary cardiomyopathy with an elusive genetic etiology. Curr Opin Pediatr (2007) 1.22
Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy. Eur Heart J (2009) 1.19
Sources of error and interpretation of plaque morphology by optical coherence tomography. Am J Cardiol (2006) 1.18
Design, methods, and evaluation directions of a multi-access service for the management of diabetes mellitus patients. Diabetes Technol Ther (2003) 1.18
Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations. J Cardiovasc Med (Hagerstown) (2009) 1.16
Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy. Hum Mol Genet (2012) 1.16
Mitochondrial cardiomyopathies: how to identify candidate pathogenic mutations by mitochondrial DNA sequencing, MITOMASTER and phylogeny. Eur J Hum Genet (2010) 1.15
A dynamic query system for supporting phenotype mining in genetic studies. Stud Health Technol Inform (2007) 1.12
Management of patients with diabetes through information technology: tools for monitoring and control of the patients' metabolic behavior. Diabetes Technol Ther (2004) 1.11
Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis. Eur J Cardiovasc Prev Rehabil (2006) 1.11
Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2012) 1.11
Risk of dissection in thoracic aneurysms associated with mutations of smooth muscle alpha-actin 2 (ACTA2). Heart (2011) 1.08
Two novel and one known mutation of the TGFBR2 gene in Marfan syndrome not associated with FBN1 gene defects. Eur J Hum Genet (2006) 1.07
Loss of lamin A/C expression revealed by immuno-electron microscopy in dilated cardiomyopathy with atrioventricular block caused by LMNA gene defects. Virchows Arch (2003) 1.06
Prognosis factors in probands with an FBN1 mutation diagnosed before the age of 1 year. Pediatr Res (2011) 1.04
Going mobile with a multiaccess service for the management of diabetic patients. J Diabetes Sci Technol (2007) 1.03
Phenotype forecasting with SNPs data through gene-based Bayesian networks. BMC Bioinformatics (2009) 1.03
R engine cell: integrating R into the i2b2 software infrastructure. J Am Med Inform Assoc (2011) 1.01
Celiac disease in patients with sporadic and inherited cardiomyopathies and in their relatives. Eur Heart J (2003) 1.01
Comprehensive overview of definitions for optical coherence tomography-based plaque and stent analyses. Coron Artery Dis (2014) 0.99
A careflow management system for chronic patients. Stud Health Technol Inform (2004) 0.98
Total erythrocyte membrane cholesterol: an innocent new marker or an active player in acute coronary syndromes? J Am Coll Cardiol (2007) 0.97
Diagnostic work-up and risk stratification in X-linked dilated cardiomyopathies caused by dystrophin defects. J Am Coll Cardiol (2011) 0.96
alphaB-crystallin mutation in dilated cardiomyopathies: low prevalence in a consecutive series of 200 unrelated probands. Biochem Biophys Res Commun (2006) 0.96
High-dose erythropoietin in patients with acute myocardial infarction: a pilot, randomised, placebo-controlled study. Int J Cardiol (2009) 0.96
Liver biopsy discloses a new apolipoprotein A-I hereditary amyloidosis in several unrelated Italian families. Gastroenterology (2004) 0.96
In-frame mutations in exon 1 of SKI cause dominant Shprintzen-Goldberg syndrome. Am J Hum Genet (2012) 0.94
Sudden anabolic steroid abuse-related death in athletes. Int J Cardiol (2005) 0.93
Determinants of quality of life in Marfan syndrome. Psychosomatics (2008) 0.93
A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy. Eur Heart J (2013) 0.92
Genetic predisposition to heart failure. Med Clin North Am (2004) 0.91
TA-clustering: cluster analysis of gene expression profiles through Temporal Abstractions. Int J Med Inform (2005) 0.90
An automated reasoning framework for translational research. J Biomed Inform (2009) 0.90
Barth syndrome associated with compound hemizygosity and heterozygosity of the TAZ and LDB3 genes. Am J Med Genet A (2007) 0.90
[Diseases associated with lamin A/C gene defects: what the clinical cardiologist ought to know]. Ital Heart J Suppl (2004) 0.90
A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy. Ann Neurol (2005) 0.89
Stage prediction of embryonic stem cell differentiation from genome-wide expression data. Bioinformatics (2011) 0.88
Aneurysm syndromes and TGF-beta receptor mutations. N Engl J Med (2006) 0.87
Bronchogenic cyst: unexpected finding in a large aneurysm of the pars membranacea septi. J Thorac Cardiovasc Surg (2006) 0.87
Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriers. Eur J Heart Fail (2012) 0.87
Network-based target ranking for polypharmacological therapies. J Biomed Inform (2013) 0.86
Telemedicine in the management of young patients with type 1 diabetes mellitus: a follow-up study. Acta Biomed (2003) 0.86
[Atrial standstill: a paralysis of cardiological relevance]. Ital Heart J Suppl (2004) 0.86
The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy. Europace (2013) 0.86
Precedence Temporal Networks to represent temporal relationships in gene expression data. J Biomed Inform (2007) 0.86
A new polymorphism in human calmodulin III gene promoter is a potential modifier gene for familial hypertrophic cardiomyopathy. Eur Heart J (2009) 0.85
Molecular imaging of the cardiac extracellular matrix. Circ Res (2014) 0.84
Text Mining approaches for automated literature knowledge extraction and representation. Stud Health Technol Inform (2010) 0.84
Heart transplantation in infants with idiopathic hypertrophic cardiomyopathy. Pediatr Transplant (2008) 0.83
The shortness of Pygmies is associated with severe under-expression of the growth hormone receptor. Mol Genet Metab (2009) 0.82
Transcriptome based identification of mouse cumulus cell markers that predict the developmental competence of their enclosed antral oocytes. BMC Genomics (2013) 0.82
When should cardiologists suspect Anderson-Fabry disease? Am J Cardiol (2010) 0.81
Concurrent upregulation of endogenous proapoptotic and antiapoptotic factors in failing human hearts. Nat Clin Pract Cardiovasc Med (2009) 0.80
Inferring gene regulatory networks by integrating static and dynamic data. Int J Med Inform (2007) 0.80
Transcriptomic and proteomic analysis in the cardiovascular setting: unravelling the disease? J Cardiovasc Med (Hagerstown) (2009) 0.80
Clinical utility gene card for: Marfan syndrome type 1 and related phenotypes [FBN1]. Eur J Hum Genet (2010) 0.80
EDG3 and SHC3 on chromosome 9q22 are co-amplified in human ependymomas. Cancer Lett (2009) 0.80
Restrictive cardiomyopathy. Curr Opin Cardiol (2009) 0.79
Quantitative expression of the mutated lamin A/C gene in patients with cardiolaminopathy. J Am Coll Cardiol (2012) 0.79
A novel mutation of the glomulin gene in an Italian family with autosomal dominant cutaneous glomuvenous malformations. Exp Dermatol (2011) 0.79
Atorvastatin and thrombogenicity of the carotid atherosclerotic plaque: the ATROCAP study. Thromb Haemost (2002) 0.79
Mouse embryonic stem cells irradiated with γ-rays differentiate into cardiomyocytes but with altered contractile properties. Mutat Res (2013) 0.79
Structures of the lamin A/C R335W and E347K mutants: implications for dilated cardiolaminopathies. Biochem Biophys Res Commun (2012) 0.79
Cell line identity finding by fingerprinting, an optimized resource for short tandem repeat profile authentication. Genet Test Mol Biomarkers (2013) 0.79
The influence of surgery, immunosuppressive drugs, and rejection, on graft function after small bowel transplantation: a large-animal study. Transpl Int (2003) 0.79
Gatekeeper of pluripotency: a common Oct4 transcriptional network operates in mouse eggs and embryonic stem cells. BMC Genomics (2011) 0.78